Gilead stock pops in after-hours trading; its experimental drug remdesivir is considered a front-runner in the race to develop a treatment for COVID-19 infections.
University of Chicago Medicine researchers said they saw “rapid recoveries” in 125 COVID-19 patients taking Gilead Sciences Inc.’s experimental drug remdesivir as part of a clinical trial, according to a Thursday afternoon report.
There are no proven treatments or vaccines for the novel coronavirus which has sickened more than two million people world-wide and killed nearly 150,000 people, but remdesivir is considered a front-runner in the race to develop a treatment for COVID-19 infections that works. Though the findings reported by Stat are promising, they are not based on full clinical trial data from the company.
According to Stat, 125 people with COVID-19 receiving care at the University of Chicago are participating in two Phase 3 clinical trials conducted by Gilead; 113 of them have severe forms of the disease. Stat said it obtained a recorded video discussion about the trial among University of Chicago faculty members in which a physician said when some people start taking the drug, fevers come down and some come off ventilators.
In a statement to Stat News on Thursday, Gilead said: “What we can say at this stage is that we look forward to data from ongoing studies becoming available.”
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead stock surges more than 10% on report of promising coronavirus treatmentGilead Sciences Inc. undefined shares rallied in the extended session Thursday following a report that one of the company's drugs showed promising results in...
Read more »
Stocks making the biggest moves after hours: Gilead, Boeing, Uber and moreCheck out the companies making headlines after the bell.
Read more »
Dow futures rally 900 points after report says Gilead drug showing effectiveness against coronavirusU.S. stock futures surged on Thursday night after a report said a Gilead Sciences drug was showing effectiveness in treating the coronavirus.
Read more »
Malaysia to step up coronavirus tests with Korean antigen rapid kitsMalaysia has approved the use of antigen rapid test kits from South Korea, as it looks to increase its coronavirus testing among high-risk groups and in places where clusters are detected, a health official said on Thursday.
Read more »
Rapid coronavirus test, commonly used in US, may miss infections in some situationsA rapid test for the novel coronavirus that was unveiled by President Trump on the White House lawn and has already been used hundreds of thousands of times can falsely produce negative results in patients who are infected, according to clinicians and laboratory experts.
Read more »
Exclusive: Ryanair sees price war fuelling rapid air travel recoveryRyanair is steeling for an airline price war that it expects to win once coronavirus restrictions are lifted and passengers flock back to tourist destinations, Chief Executive Michael O'Leary told Reuters on Wednesday.
Read more »